rs542096066

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_001131025.2(PEX5):​c.-145G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00279 in 1,491,518 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0019 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0029 ( 6 hom. )

Consequence

PEX5
NM_001131025.2 5_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.49

Publications

0 publications found
Variant links:
Genes affected
PEX5 (HGNC:9719): (peroxisomal biogenesis factor 5) The product of this gene binds to the C-terminal PTS1-type tripeptide peroxisomal targeting signal (SKL-type) and plays an essential role in peroxisomal protein import. Peroxins (PEXs) are proteins that are essential for the assembly of functional peroxisomes. The peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous autosomal recessive, lethal diseases characterized by multiple defects in peroxisome function. The peroxisomal biogenesis disorders are a heterogeneous group with at least 14 complementation groups and with more than 1 phenotype being observed in cases falling into particular complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene are a cause of neonatal adrenoleukodystrophy (NALD), a cause of Zellweger syndrome (ZWS) as well as may be a cause of infantile Refsum disease (IRD). Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Oct 2008]
PEX5 Gene-Disease associations (from GenCC):
  • peroxisome biogenesis disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • peroxisome biogenesis disorder 2A (Zellweger)
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • peroxisome biogenesis disorder 2B
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • rhizomelic chondrodysplasia punctata type 5
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • Zellweger spectrum disorders
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00189 (288/152118) while in subpopulation NFE AF = 0.0031 (211/67970). AF 95% confidence interval is 0.00276. There are 0 homozygotes in GnomAd4. There are 129 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001131025.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PEX5
NM_001351132.2
MANE Select
c.-16-274G>A
intron
N/ANP_001338061.1P50542-1
PEX5
NM_001131025.2
c.-145G>A
5_prime_UTR
Exon 1 of 16NP_001124497.1A0A0S2Z4H1
PEX5
NM_001131026.2
c.-145G>A
5_prime_UTR
Exon 2 of 18NP_001124498.1P50542-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PEX5
ENST00000420616.6
TSL:1
c.-145G>A
5_prime_UTR
Exon 1 of 16ENSP00000410159.2P50542-1
PEX5
ENST00000675855.1
MANE Select
c.-16-274G>A
intron
N/AENSP00000502374.1P50542-1
PEX5
ENST00000266563.9
TSL:1
c.-16-274G>A
intron
N/AENSP00000266563.5P50542-2

Frequencies

GnomAD3 genomes
AF:
0.00189
AC:
288
AN:
152000
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000483
Gnomad AMI
AF:
0.0363
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.000389
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00310
Gnomad OTH
AF:
0.000479
GnomAD4 exome
AF:
0.00289
AC:
3876
AN:
1339400
Hom.:
6
Cov.:
32
AF XY:
0.00290
AC XY:
1916
AN XY:
659834
show subpopulations
African (AFR)
AF:
0.000659
AC:
19
AN:
28836
American (AMR)
AF:
0.000798
AC:
17
AN:
21300
Ashkenazi Jewish (ASJ)
AF:
0.00194
AC:
44
AN:
22670
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35436
South Asian (SAS)
AF:
0.00239
AC:
173
AN:
72260
European-Finnish (FIN)
AF:
0.000485
AC:
16
AN:
32964
Middle Eastern (MID)
AF:
0.00388
AC:
18
AN:
4638
European-Non Finnish (NFE)
AF:
0.00325
AC:
3465
AN:
1065460
Other (OTH)
AF:
0.00222
AC:
124
AN:
55836
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
203
406
608
811
1014
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
138
276
414
552
690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00189
AC:
288
AN:
152118
Hom.:
0
Cov.:
32
AF XY:
0.00173
AC XY:
129
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.000482
AC:
20
AN:
41524
American (AMR)
AF:
0.000131
AC:
2
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3466
East Asian (EAS)
AF:
0.000390
AC:
2
AN:
5128
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4822
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00310
AC:
211
AN:
67970
Other (OTH)
AF:
0.000474
AC:
1
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
13
26
40
53
66
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00256
Hom.:
0
Bravo
AF:
0.00207
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Peroxisome biogenesis disorder 2A (Zellweger) (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
13
DANN
Benign
0.96
PhyloP100
1.5
PromoterAI
-0.022
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=297/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs542096066; hg19: chr12-7342684; API